List of RayBiotech patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11137395 SARS-CoV-2 (COVID-19) spike-AXL binding assay	Patent 11137395 was granted and assigned to RayBiotech on October, 2021 by the United States Patent and Trademark Office.	RayBiotech	RayBiotech	United States Patent and Trademark Office	11137395	October 5, 2021
‌ US Patent 11249083 Covid-19 spike-ACE2 binding assay for drug and antibody screening	Patent 11249083 was granted and assigned to RayBiotech on February, 2022 by the United States Patent and Trademark Office.	RayBiotech	RayBiotech	United States Patent and Trademark Office	11249083	February 15, 2022
‌ US Patent 11105804 COVID-19 spike-ACE2 binding assay for drug and antibody screening	Patent 11105804 was granted and assigned to RayBiotech on August, 2021 by the United States Patent and Trademark Office.	RayBiotech	RayBiotech	United States Patent and Trademark Office	11105804	August 31, 2021
‌ US Patent 11255855 COVID-19 spike-ACE2 binding assay for drug and antibody screening	Patent 11255855 was granted and assigned to RayBiotech on February, 2022 by the United States Patent and Trademark Office.	RayBiotech	RayBiotech	United States Patent and Trademark Office	11255855	February 22, 2022
‌ US Patent 10444238 Detection of ovarian cancer using antibody arrays	Patent 10444238 was granted and assigned to RayBiotech on October, 2019 by the United States Patent and Trademark Office.		RayBiotech	United States Patent and Trademark Office	10444238	October 15, 2019